I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Gabrail, N.
18
results:
Search for persons
X
Format
Online (18)
Mediatypes
Articles (Online) (15)
OpenAccess-fulltext (3)
Sorted by: Relevance
Sorted by: Year
?
1
A Phase 1 Dose-escalation and Expansion Study of CUE-101, G..:
Colevas, A.D.
;
Chung, C.H.
;
Adkins, D.
...
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e87 , 2024
Link:
https://doi.org/10.1016/..
?
2
The Keynote B36 (EF-36) Pilot Study of Tumor Treating Field..:
Chen, A.B.
;
Kotecha, R.
;
Chaney, M.
...
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 1 - p. e8 , 2024
Link:
https://doi.org/10.1016/..
?
3
Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III:..:
Savona, M.
;
Mccloskey, J.
;
Griffiths, E.
...
Leukemia Research. 128 (2023) - p. 107271 , 2023
Link:
https://doi.org/10.1016/..
?
4
P2.12-07 Phase II Trial of LP-300 + Pemetrexed/Carboplatin ..:
Treat, J.
;
Abdulla, N.
;
Bank, B.
...
Journal of Thoracic Oncology. 18 (2023) 11 - p. S365 , 2023
Link:
https://doi.org/10.1016/..
?
5
Topic: AS08-Treatment/AS08a-Current treatment options - Hyp..:
Savona, M.
;
Mccloskey, J.
;
Griffiths, E.
...
Leukemia Research. 108 (2021) - p. 106681.47 , 2021
Link:
https://doi.org/10.1016/..
?
6
Oprozomib (OPZ) and Dexamethasone (DEX) in Patients (Pts) W..:
Prada, C.P.
;
Shain, K.H.
;
Voorhees, P.
...
Clinical Lymphoma Myeloma and Leukemia. 15 (2015) - p. e273 , 2015
Link:
https://doi.org/10.1016/..
?
7
P1334 : A multicentre, randomised, open-label study compari..:
Merle, P.
;
Pelletier, G.
;
Habersetzer, F.
...
Journal of Hepatology. 62 (2015) - p. S856-S857 , 2015
Link:
https://doi.org/10.1016/..
?
8
330 First-in-man study of gemcitabine hydrochloride oral fo..:
Gabrail, N.
;
Ghamande, S.
;
Silverman, M.
...
European Journal of Cancer. 51 (2015) - p. S64 , 2015
Link:
https://doi.org/10.1016/..
?
9
3011 POSTER 18-Month Safety Analysis of Fentanyl Pectin Nas..:
Torres, L.
;
Lynch, L.
;
Revnic, J.
...
European Journal of Cancer. 47 (2011) - p. S225 , 2011
Link:
https://doi.org/10.1016/..
?
10
Abstract No. 147: A phase III, randomized, double-blind, pl..:
Gabrail, N.
;
Sandler, E.
;
Charu, V.
...
Journal of Vascular and Interventional Radiology. 21 (2010) 2 - p. S57-S58 , 2010
Link:
https://doi.org/10.1016/..
?
11
467 Updated efficacy and safety results for a randomized ph..:
Garon, E.B.
;
Neidhart, J.
;
Neidhart, J.D.
...
European Journal of Cancer Supplements. 8 (2010) 7 - p. 150 , 2010
Link:
https://doi.org/10.1016/..
?
12
P-565 A Phase II study of KOS-862 (Epothilone D) as second-..:
Rizvi, N.
;
Villalona-Calero, M.
;
Lynch, T.
...
Lung Cancer. 49 (2005) - p. S266-S267 , 2005
Link:
https://doi.org/10.1016/..
?
13
PCN2 IMPACT OF CHEMOTHERAPY-INDUCED DIARRHEA ON MANAGEMENT ..:
Arnold, RJ
;
Gabrail, N
;
Raut, M
...
Value in Health. 7 (2004) 3 - p. 246 , 2004
Link:
https://doi.org/10.1016/..
?
14
A phase 2 randomized dose-ranging study of the JAK2-selecti..:
Pardanani, A
;
Tefferi, A
;
Jamieson, C
...
Blood Cancer Journal. 5 (2015) 8 - p. e335-e335 , 2015
Link:
https://doi.org/10.1038/..
?
15
APF530 versus ondansetron, each in a guideline-recommended ..:
Schnadig ID
;
Agajanian R
;
Dakhil C
...
https://www.dovepress.com/apf530-versus-ondansetron-each-in-a-guideline-recommended-three-drug-r-peer-reviewed-article-CMAR. , 2017
Link:
https://doaj.org/article..
1-15